A detailed history of Dixon Mitchell Investment Counsel Inc. transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Dixon Mitchell Investment Counsel Inc. holds 79,273 shares of TMO stock, worth $40.7 Million. This represents 2.23% of its overall portfolio holdings.

Number of Shares
79,273
Previous 90,936 12.83%
Holding current value
$40.7 Million
Previous $50.5 Billion 2.8%
% of portfolio
2.23%
Previous 2.53%

Shares

46 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$531.86 - $624.21 $6.2 Million - $7.28 Million
-11,663 Reduced 12.83%
79,273 $49.1 Billion
Q2 2024

Jul 11, 2024

SELL
$541.52 - $599.02 $374,731 - $414,521
-692 Reduced 0.76%
90,936 $50.5 Billion
Q1 2024

Apr 18, 2024

SELL
$528.82 - $599.43 $259,650 - $294,320
-491 Reduced 0.53%
91,628 $53.3 Billion
Q4 2023

Jan 17, 2024

BUY
$431.41 - $532.94 $11.5 Million - $14.3 Million
26,770 Added 40.96%
92,119 $48.9 Billion
Q3 2023

Jan 17, 2024

SELL
$498.29 - $574.41 $352,789 - $406,682
-708 Reduced 1.07%
65,349 $33.1 Billion
Q2 2023

Jan 17, 2024

BUY
$508.46 - $591.13 $1.37 Million - $1.6 Million
2,701 Added 4.26%
66,057 $34.5 Billion
Q1 2023

Jan 17, 2024

SELL
$535.0 - $604.82 $1.09 Million - $1.23 Million
-2,032 Reduced 3.11%
63,356 $36.5 Billion
Q4 2022

Jan 17, 2024

BUY
$484.71 - $571.37 $415,396 - $489,664
857 Added 1.33%
65,388 $36 Billion
Q3 2022

Jan 17, 2024

SELL
$507.19 - $604.49 $20.7 Million - $24.7 Million
-40,911 Reduced 38.8%
64,531 $32.7 Billion
Q2 2022

Jan 17, 2024

BUY
$500.9 - $612.21 $165,797 - $202,641
331 Added 0.31%
105,442 $57.3 Billion
Q1 2022

Jan 17, 2024

BUY
$524.0 - $644.92 $1.33 Million - $1.64 Million
2,540 Added 2.48%
105,111 $62.1 Billion
Q4 2021

Jan 17, 2024

BUY
$569.0 - $667.24 $1.3 Million - $1.52 Million
2,276 Added 2.27%
102,571 $68.4 Billion
Q3 2021

Jan 17, 2024

SELL
$509.53 - $609.78 $1.19 Million - $1.43 Million
-2,338 Reduced 2.28%
100,295 $57.3 Billion
Q2 2021

Jan 17, 2024

SELL
$441.0 - $508.24 $193,599 - $223,117
-439 Reduced 0.43%
102,633 $51.8 Billion
Q1 2021

Jan 17, 2024

BUY
$439.85 - $518.83 $21,992 - $25,941
50 Added 0.05%
103,072 $47 Billion
Q4 2020

Jan 17, 2024

SELL
$435.06 - $527.66 $8.06 Million - $9.78 Million
-18,526 Reduced 15.24%
103,022 $48 Billion
Q3 2020

Jan 17, 2024

SELL
$359.77 - $441.52 $8.62 Million - $10.6 Million
-23,964 Reduced 16.47%
121,548 $53.7 Billion
Q2 2020

Jan 17, 2024

SELL
$275.2 - $362.34 $1.83 Million - $2.41 Million
-6,644 Reduced 4.37%
145,512 $52.7 Billion
Q1 2020

Jan 17, 2024

BUY
$255.3 - $340.05 $4.87 Million - $6.49 Million
19,081 Added 14.34%
152,156 $43.2 Billion
Q4 2019

Jan 17, 2024

SELL
$271.93 - $328.04 $2.71 Million - $3.27 Million
-9,973 Reduced 6.97%
133,075 $43.2 Billion
Q3 2019

Jan 17, 2024

SELL
$268.46 - $305.43 $377,723 - $429,740
-1,407 Reduced 0.97%
143,048 $41.7 Billion
Q2 2019

Jan 17, 2024

BUY
$257.51 - $295.55 $162,231 - $186,196
630 Added 0.44%
144,455 $42.4 Billion
Q1 2019

Jan 17, 2024

SELL
$212.17 - $273.72 $424,764 - $547,987
-2,002 Reduced 1.37%
143,825 $39.4 Billion
Q4 2018

Jan 17, 2024

SELL
$208.47 - $251.98 $151,557 - $183,189
-727 Reduced 0.5%
145,827 $32.6 Billion
Q3 2018

Jan 17, 2024

BUY
$205.57 - $244.32 $31,863 - $37,869
155 Added 0.11%
146,554 $35.8 Billion
Q2 2018

Jan 17, 2024

BUY
$203.14 - $219.53 $9.72 Million - $10.5 Million
47,859 Added 48.57%
146,399 $30.3 Billion
Q1 2018

Jan 17, 2024

SELL
$192.98 - $224.11 $260,523 - $302,548
-1,350 Reduced 1.35%
98,540 $20.3 Billion
Q4 2017

Jan 17, 2024

SELL
$182.03 - $200.37 $166,557 - $183,338
-915 Reduced 0.91%
99,890 $19 Billion
Q3 2017

Jan 17, 2024

BUY
$171.74 - $194.04 $4.84 Million - $5.47 Million
28,165 Added 38.77%
100,805 $19.1 Billion
Q2 2017

Jan 17, 2024

SELL
N/A
-776 Reduced 1.06%
72,640 $12.7 Billion
Q1 2017

Jan 17, 2024

BUY
N/A
711 Added 0.98%
73,416 $11.3 Billion
Q4 2016

Jan 17, 2024

SELL
N/A
-1,217 Reduced 1.65%
72,705 $10.3 Billion
Q3 2016

Jan 17, 2024

BUY
N/A
484 Added 0.66%
73,922 $11.8 Billion
Q2 2016

Jan 17, 2024

SELL
N/A
-643 Reduced 0.87%
73,438 $10.9 Billion
Q1 2016

Jan 17, 2024

SELL
N/A
-3,727 Reduced 4.79%
74,081 $10.5 Billion
Q4 2015

Jan 17, 2024

SELL
N/A
-551 Reduced 0.7%
77,808 $11 Billion
Q3 2015

Jan 17, 2024

SELL
N/A
-31,268 Reduced 28.52%
78,359 $9.58 Billion
Q2 2015

Jan 17, 2024

BUY
N/A
852 Added 0.78%
109,627 $14.2 Billion
Q1 2015

Jan 17, 2024

SELL
N/A
-468 Reduced 0.43%
108,775 $14.6 Billion
Q3 2014

Jan 17, 2024

SELL
N/A
-1,443 Reduced 1.3%
109,243 $13.3 Billion
Q2 2014

Jan 17, 2024

BUY
N/A
205 Added 0.19%
110,686 $13.1 Billion
Q1 2014

Jan 17, 2024

SELL
N/A
-4,286 Reduced 3.73%
110,481 $13.3 Billion
Q4 2013

Jan 17, 2024

SELL
N/A
-2,594 Reduced 2.21%
114,767 $12.8 Billion
Q3 2013

Jan 17, 2024

BUY
N/A
632 Added 0.54%
117,361 $10.8 Billion
Q2 2013

Jan 17, 2024

BUY
N/A
30,489 Added 35.35%
116,729 $9.88 Billion
Q1 2013

Jan 17, 2024

BUY
N/A
86,240
86,240 $6.6 Billion

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $201B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Dixon Mitchell Investment Counsel Inc. Portfolio

Follow Dixon Mitchell Investment Counsel Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dixon Mitchell Investment Counsel Inc., based on Form 13F filings with the SEC.

News

Stay updated on Dixon Mitchell Investment Counsel Inc. with notifications on news.